Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrey Khrunin is active.

Publication


Featured researches published by Andrey Khrunin.


PLOS ONE | 2009

Genetic Structure of Europeans: A View from the North–East

Mari Nelis; Tonu Esko; Reedik Mägi; Fritz Zimprich; Alexander Zimprich; Draga Toncheva; Sena Karachanak; T. Piskackova; I. Balascak; Leena Peltonen; Eveliina Jakkula; Karola Rehnström; Mark Lathrop; Simon Heath; Pilar Galan; Stefan Schreiber; Thomas Meitinger; Arne Pfeufer; H-Erich Wichmann; Béla Melegh; Noémi Polgár; Daniela Toniolo; Paolo Gasparini; Pio D'Adamo; Janis Klovins; Liene Nikitina-Zake; Vaidutis Kučinskas; Jūratė Kasnauskienė; Jan Lubinski; Tadeusz Dębniak

Using principal component (PC) analysis, we studied the genetic constitution of 3,112 individuals from Europe as portrayed by more than 270,000 single nucleotide polymorphisms (SNPs) genotyped with the Illumina Infinium platform. In cohorts where the sample size was >100, one hundred randomly chosen samples were used for analysis to minimize the sample size effect, resulting in a total of 1,564 samples. This analysis revealed that the genetic structure of the European population correlates closely with geography. The first two PCs highlight the genetic diversity corresponding to the northwest to southeast gradient and position the populations according to their approximate geographic origin. The resulting genetic map forms a triangular structure with a) Finland, b) the Baltic region, Poland and Western Russia, and c) Italy as its vertexes, and with d) Central- and Western Europe in its centre. Inter- and intra- population genetic differences were quantified by the inflation factor lambda (λ) (ranging from 1.00 to 4.21), fixation index (Fst) (ranging from 0.000 to 0.023), and by the number of markers exhibiting significant allele frequency differences in pair-wise population comparisons. The estimated lambda was used to assess the real diminishing impact to association statistics when two distinct populations are merged directly in an analysis. When the PC analysis was confined to the 1,019 Estonian individuals (0.1% of the Estonian population), a fine structure emerged that correlated with the geography of individual counties. With at least two cohorts available from several countries, genetic substructures were investigated in Czech, Finnish, German, Estonian and Italian populations. Together with previously published data, our results allow the creation of a comprehensive European genetic map that will greatly facilitate inter-population genetic studies including genome wide association studies (GWAS).


Pharmacogenomics Journal | 2010

Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients.

Andrey Khrunin; Alexey Moisseev; Vera Gorbunova; S. A. Limborska

Platinum drugs are among the most active and widely used agents in the treatment of different cancers. However, the great individual variability in both outcome and toxicity of platinum chemotherapy requires the identification of genetic markers that can be used to screen patients before treatment. In this study, 21 polymorphisms in 10 genes, the protein activities of which may be addressed in different aspects of cisplatin metabolism, were tested for correlations with efficacy and toxicity of cisplatin–cyclophosphamide regimen in 104 ovarian cancer patients. The glutathione S-transferase P1 (GSTP1) Ile105Val polymorphism was strongly associated with progression-free survival (χ2=12.12, P=0.002). The allelic status of the GSTA1 –69 C>T polymorphism correlated with the overall survival: patients with T/T genotype survived longer than C/C carriers (P=0.044). Thrombocytopenia, anemia and neuropathy were less frequent among patients with the GSTM1-null or GSTM3 intron 6 AGG/AGG genotypes. Severe neutropenia was associated with the TP53 72 Pro/Pro, XPD 312 Asp/Asn and XRCC1 399 Arg/Arg genotypes. A higher risk of nephrotoxicity was noted for patients with the heterozygous ERCC1 19007 T/C and 8092 C/A genotypes. No correlations were found between genotypes and complete tumor responses.


European Journal of Human Genetics | 2013

Genetic characterization of northeastern Italian population isolates in the context of broader European genetic diversity

Tonu Esko; Massimo Mezzavilla; Mari Nelis; Christelle Borel; Tadeusz Dębniak; Eveliina Jakkula; Antonio Julià; Sena Karachanak; Andrey Khrunin; Péter Kisfali; Veronika Krulisova; Zita Ausrele Kucinskiene; Karola Rehnström; Michela Traglia; Liene Nikitina-Zake; Fritz Zimprich; Xavier Estivill; Damjan Glavač; Ivo Gut; Janis Klovins; Michael Krawczak; Vaidutis Kučinskas; Mark Lathrop; Milan Macek; Sara Marsal; Thomas Meitinger; Béla Melegh; S. A. Limborska; Jan Lubinski; Aarno Paolotie

Population genetic studies on European populations have highlighted Italy as one of genetically most diverse regions. This is possibly due to the country’s complex demographic history and large variability in terrain throughout the territory. This is the reason why Italy is enriched for population isolates, Sardinia being the best-known example. As the population isolates have a great potential in disease-causing genetic variants identification, we aimed to genetically characterize a region from northeastern Italy, which is known for isolated communities. Total of 1310 samples, collected from six geographically isolated villages, were genotyped at >145 000 single-nucleotide polymorphism positions. Newly genotyped data were analyzed jointly with the available genome-wide data sets of individuals of European descent, including several population isolates. Despite the linguistic differences and geographical isolation the village populations still show the greatest genetic similarity to other Italian samples. The genetic isolation and small effective population size of the village populations is manifested by higher levels of genomic homozygosity and elevated linkage disequilibrium. These estimates become even more striking when the detected substructure is taken into account. The observed level of genetic isolation in Friuli-Venezia Giulia region is more extreme according to several measures of isolation compared with Sardinians, French Basques and northern Finns, thus proving the status of an isolate.


Nucleic Acids Research | 2008

Development of a single tube 640-plex genotyping method for detection of nucleic acid variations on microarrays

Kaarel Krjutškov; Reidar Andreson; Reedik Mägi; Tiit Nikopensius; Andrey Khrunin; Evelin Mihailov; Veronika Tammekivi; Helena Sork; Maido Remm; Andres Metspalu

Detection of DNA sequence variation is critical to biomedical applications, including disease genetic identification, diagnosis and treatment, drug discovery and forensic analysis. Here, we describe an arrayed primer extension-based genotyping method (APEX-2) that allows multiplex (640-plex) DNA amplification and detection of single nucleotide polymorphisms (SNPs) and mutations on microarrays via four-color single-base primer extension. The founding principle of APEX-2 multiplex PCR requires two oligonucleotides per SNP/mutation to generate amplicons containing the position of interest. The same oligonucleotides are then subsequently used as immobilized single-base extension primers on a microarray. The method described here is ideal for SNP or mutation detection analysis, molecular diagnostics and forensic analysis. This robust genetic test has minimal requirements: two primers, two spots on the microarray and a low cost four-color detection system for the targeted site; and provides an advantageous alternative to high-density platforms and low-density detection systems.


Pharmacogenomics | 2012

Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins

Andrey Khrunin; Feodosia Ivanova; Alexey Moisseev; D. V. Khokhrin; Yuliya Sleptsova; Vera Gorbunova; S. A. Limborska

AIM There is a substantial difference between Asians and Caucasians in their reaction to platinum drugs. To determine whether population-related genomics contribute to differences in patient outcomes, pharmacogenomic relevance of polymorphisms in some genes, the protein activities of which may affect aspects of cisplatin metabolism, were evaluated. PATIENTS & METHODS Nineteen polymorphisms in ten genes were tested for correlations with the efficacy and toxicity of a cisplatin-cyclophosphamide regimen in Yakut and Russian patients with ovarian cancer. RESULTS The CYP2E1 7632T>A polymorphism was associated with progression-free survival (p = 0.015) in Yakuts. In Russians, progression-free survival was correlated with the GSTP1 Ile105Val polymorphism (p = 0.004). Yakut patients with the GSTT1-null genotype had a higher risk for nephrotoxicity. By contrast, in the Russian group, nephrotoxicity was more frequent among patients with heterozygous ERCC1 genotypes. Severe emesis in Yakuts was independently associated with two polymorphisms in the CYP2E1 gene but in Russians, it was more common in patients with the GSTT1-null genotype. Differences in genotypic correlations with anemia were also observed. CONCLUSION Significant differences in genotype distribution between Russian and Yakut women were observed for ten of the 19 polymorphisms, but none of them seemed to be a clear casual candidate and further studies involving more markers are required.


Pharmacogenomics | 2014

Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer

Andrey Khrunin; D. V. Khokhrin; Alexey Moisseev; Vera Gorbunova; S. A. Limborska

AIM Cisplatin and its analogs are potent antitumor agents. However, their use is restricted by significant variability in tumor response and toxicity. There is a great need to identify genetic markers to predict the most important adverse events and patient outcomes. MATERIALS & METHODS We have evaluated the association between polymorphisms in 106 genes involved mainly in xenobiotic metabolism, DNA repair, the cell cycle and apoptosis, and outcomes in 104 ovarian cancer patients receiving cisplatin-cyclophosphamide chemotherapy. Arrayed primer extension technology was used to genotype 228 SNPs. RESULTS Ten SNPs in nine genes were found to be associated with one or more of the assessed clinical end points. SNPs in TPMT and NQO1 were significantly associated with progression-free survival. Polymorphisms in ERCC5, RAD52, MUTYH and LIG3 correlated with the occurrence of severe neutropenia. SNPs in NAT2 and EPHX1 were associated with anemia and nephrotoxicity, respectively. A SNP in ADH1C was correlated with complete tumor response. CONCLUSION The results obtained suggest that SNPs in different genes involved in drug metabolism can be important in identifying patients at risk for nonresponse to or toxicity from cisplatin-based treatment.


JAMA Psychiatry | 2016

Evidence for Genetic Overlap Between Schizophrenia and Age at First Birth in Women

Divya Mehta; Felix C. Tropf; Jacob Gratten; Andrew Bakshi; Zhihong Zhu; Silviu-Alin Bacanu; Gibran Hemani; Patrik K. E. Magnusson; Nicola Barban; Tonu Esko; Andres Metspalu; Harold Snieder; Bryan J. Mowry; Kenneth S. Kendler; Jian Yang; Peter M. Visscher; John J. McGrath; Melinda Mills; Naomi R. Wray; S. Hong Lee; Ole A. Andreassen; Elvira Bramon; Richard Bruggeman; Joseph D. Buxbaum; Murray J. Cairns; Rita M. Cantor; C. Robert Cloninger; David Cohen; Benedicto Crespo-Facorro; Ariel Darvasi

IMPORTANCE A recently published study of national data by McGrath et al in 2014 showed increased risk of schizophrenia (SCZ) in offspring associated with both early and delayed parental age, consistent with a U-shaped relationship. However, it remains unclear if the risk to the child is due to psychosocial factors associated with parental age or if those at higher risk for SCZ tend to have children at an earlier or later age. OBJECTIVE To determine if there is a genetic association between SCZ and age at first birth (AFB) using genetically informative but independently ascertained data sets. DESIGN, SETTING, AND PARTICIPANTS This investigation used multiple independent genome-wide association study data sets. The SCZ sample comprised 18 957 SCZ cases and 22 673 controls in a genome-wide association study from the second phase of the Psychiatric Genomics Consortium, and the AFB sample comprised 12 247 genotyped women measured for AFB from the following 4 community cohorts: Estonia (Estonian Genome Center Biobank, University of Tartu), the Netherlands (LifeLines Cohort Study), Sweden (Swedish Twin Registry), and the United Kingdom (TwinsUK). Schizophrenia genetic risk for each woman in the AFB community sample was estimated using genetic effects inferred from the SCZ genome-wide association study. MAIN OUTCOMES AND MEASURES We tested if SCZ genetic risk was a significant predictor of response variables based on published polynomial functions that described the relationship between maternal age and SCZ risk in offspring in Denmark. We substituted AFB for maternal age in these functions, one of which was corrected for the age of the father, and found that the fit was superior for the model without adjustment for the fathers age. RESULTS We observed a U-shaped relationship between SCZ risk and AFB in the community cohorts, consistent with the previously reported relationship between SCZ risk in offspring and maternal age when not adjusted for the age of the father. We confirmed that SCZ risk profile scores significantly predicted the response variables (coefficient of determination R2 = 1.1E-03, P = 4.1E-04), reflecting the published relationship between maternal age and SCZ risk in offspring by McGrath et al in 2014. CONCLUSIONS AND RELEVANCE This study provides evidence for a significant overlap between genetic factors associated with risk of SCZ and genetic factors associated with AFB. It has been reported that SCZ risk associated with increased maternal age is explained by the age of the father and that de novo mutations that occur more frequently in the germline of older men are the underlying causal mechanism. This explanation may need to be revised if, as suggested herein and if replicated in future studies, there is also increased genetic risk of SCZ in older mothers.


PLOS ONE | 2013

A Genome-Wide Analysis of Populations from European Russia Reveals a New Pole of Genetic Diversity in Northern Europe

Andrey Khrunin; D. V. Khokhrin; Irina N. Filippova; Tonu Esko; Mari Nelis; Natalia A. Bebyakova; Natalia L. Bolotova; Janis Klovins; Liene Nikitina-Zake; Karola Rehnström; Samuli Ripatti; Stefan Schreiber; Andre Franke; Milan Macek; Veronika Krulisova; Jan Lubinski; Andres Metspalu; S. A. Limborska

Several studies examined the fine-scale structure of human genetic variation in Europe. However, the European sets analyzed represent mainly northern, western, central, and southern Europe. Here, we report an analysis of approximately 166,000 single nucleotide polymorphisms in populations from eastern (northeastern) Europe: four Russian populations from European Russia, and three populations from the northernmost Finno-Ugric ethnicities (Veps and two contrast groups of Komi people). These were compared with several reference European samples, including Finns, Estonians, Latvians, Poles, Czechs, Germans, and Italians. The results obtained demonstrated genetic heterogeneity of populations living in the region studied. Russians from the central part of European Russia (Tver, Murom, and Kursk) exhibited similarities with populations from central–eastern Europe, and were distant from Russian sample from the northern Russia (Mezen district, Archangelsk region). Komi samples, especially Izhemski Komi, were significantly different from all other populations studied. These can be considered as a second pole of genetic diversity in northern Europe (in addition to the pole, occupied by Finns), as they had a distinct ancestry component. Russians from Mezen and the Finnic-speaking Veps were positioned between the two poles, but differed from each other in the proportions of Komi and Finnic ancestries. In general, our data provides a more complete genetic map of Europe accounting for the diversity in its most eastern (northeastern) populations.


Russian Journal of Genetics | 2005

Polymorphism of Y-Chromosomal Microsatellites in Russian Populations from the Northern and Southern Russia as Exemplified by the Populations of Kursk and Arkhangelsk Oblast

Andrey Khrunin; N. A. Bebyakova; V. P. Ivanov; M. A. Solodilova; S. A. Limborska

Allelic polymorphisms at five Y-chromosomal microsatellite loci (DYS19, DYS390, DYS391, DYS392, and DYS393) were typed in 87 individuals from male population samples from two geographically isolated regions (Arkhangelsk oblast and Kursk oblast) of the European part of Russia. The populations examined demonstrated substantial differences in the distribution of the DYS392 (P = 0.005) and DYS393 (P = 0.003) alleles. Estimates of genetic relationships between these populations and some other European populations (including Eastern-Slavic) showed that irrespectively of the measure of genetic distance chosen, Arkhangelsk population was closer to the populations belonging to the Finno-Ugric linguistic group (Saami and Estonians) and to the Estonian geographical neighbors, Latvians, while Kursk population was the member of a cluster formed by Eastern-Slavic populations (Russians of Novgorod oblast, Ukrainians, and Belarussians). Phylogenetic analysis of the most frequent haplotypes indicated that these differences between Kursk and Arkhangelsk populations were associated with high prevalence in the latter of major haplotypes characteristic primarily of the Finno-Ugric populations.


Human Heredity | 2009

Analysis of allele and haplotype diversity across 25 genomic regions in three Eastern European populations.

Andrey Khrunin; Evelin Mihailov; Tiit Nikopensius; Kaarel Krjutškov; S. A. Limborska; Andres Metspalu

Objective: Individual population history is the main reason for the variability of linkage disequilibrium (LD) patterns and haplotype frequencies among populations. Such diversity may influence the transferability of tag SNPs from one population to another. Our goal was to compare patterns of pairwise LD and allele and haplotype frequencies in Estonian and Russian populations, to estimate the genetic variation between populations and assess the potential transferability of tag SNPs. Methods: 452 SNPs from 25 unlinked genomic regions on 12 chromosomes were genotyped in 140 Estonians and 207 Russians from Northern and Western regions of the European area of Russia. Results: The allele frequency distributions were highly consistent between populations (R > 0.90 for all pairwise comparisons). The overall frequency variation among populations was low (FST = 0.0054). The number of SNPs with high-range FST values (0.02–0.09) was most prominent for the MC5R genomic region. Haplotype heterogeneity among populations was low (FST values ranged within 0.00–0.01, with the exception of haploblocks in the ADIPOR2 and MC5R regions). The interpopulation proximity was also evaluated using haplotype diversity. Conclusion: Our data showed a high concordance between the populations studied, which may be considered as the result of their historical formation on a cognate genetic basis.

Collaboration


Dive into the Andrey Khrunin's collaboration.

Top Co-Authors

Avatar

S. A. Limborska

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

D. V. Khokhrin

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Dmitry A. Verbenko

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Irina N. Filippova

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Karola Rehnström

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jan Lubinski

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar

Janis Klovins

Latvian Biomedical Research and Study centre

View shared research outputs
Researchain Logo
Decentralizing Knowledge